Wafernyl™ - for breakthrough cancer pain

Wafernyl™ is a sublingual fentanyl oral wafer which utilises iX's proprietary WaferiX™ techology. It is being developed for use in breakthrough cancer pain. 

A pharmacokinetic study in 24 healthy volunteers comparing Wafernyl 100mcg to IV fentanyl 100mcg demonstrated Wafernyl had rapid systemic absorption with detectable fentanyl in plasma at 2 minutes post administration and an absolute bioavailability of 79%.

Absolute Bioavailability Study


Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170
E: info@ixbiopharma.com